Help Your Clients Save Big on Pharmacy Benefits
Impress your clients with a smart, no-cost analysis that uncovers hidden pharmacy benefit savings.
From specialty drug surges to regulatory shifts, explore what’s ahead for pharmacy costs and how Intercept Rx’s Rx Optimization Program can help control them.
Key takeaways
- Specialty drugs may account for up to 60% of total drug spending by year-end
- New legislation is transforming drug pricing rules and compliance challenges
- Biosimilars are unlocking major savings without compromising care
- AI and blockchain are reshaping transparency and smarter plan design
- Rising drug costs are causing employees to delay or skip needed care
- Strong, affordable pharmacy benefits are crucial to attracting and retaining talent
- The Rx Optimization Program helps employers reduce spend and improve access
- Proactive planning is the key to managing 2025/2026 pharmacy benefit trends
What’s really going on with drug prices in 2025?
Prescription drug costs are still on the rise and it’s hitting both companies and employees hard. For employers offering health benefits, finding ways to manage pharmacy spend has never been more important. At the same time, employees are struggling to afford the medications they need to stay healthy and productive at work.
So, what’s behind the rising costs in the second half of 2025? A few things:
- Specialty medications are a major driver. These high-cost treatments can be life-changing, but they come with big price tags that quickly inflate benefit plan costs.
- Biosimilars, the affordable alternatives to brand-name biologics, are showing up more in the market and could bring savings if more people start using them.
- New regulations at both the state and federal levels are reshaping how drugs are priced and how pharmacy benefit managers (PBMs) operate. That means employers and brokers need to stay flexible and up to date.
For small and mid-sized businesses especially, this all adds up to tough decisions. Many are having to cut back on coverage or shift more costs to employees which leads to frustration, financial stress, and unhappy teams.¹
If companies want to stay competitive, they need more than the usual pharmacy benefits. They need smarter, transparent, and cost-saving solutions.
That’s exactly where Intercept Rx comes in. As a modern Pharmacy Benefit Solutions provider, Intercept Rx offers better ways to manage costs while still giving employees access to the medications they count on.
The national push for lower drug prices and where Intercept Rx stands
There’s been a growing national effort to make prescription medications more affordable and it’s picking up speed. One example? During his presidency, Donald J. Trump introduced the “American Patients First” blueprint, a federal plan focused on bringing more transparency, fairness, and competition to drug pricing.
This plan called for:
- Greater visibility into how drug prices are set
- Stronger competition to drive down costs
- The removal of hidden incentives that benefit middlemen instead of patients
This federal focus set the tone: the old ways of managing pharmacy benefits weren’t working and change was coming.
Intercept Rx has been on this mission from day one
While national policy continues to evolve, Intercept Rx has been aligned with this mission all along. We’ve built our Pharmacy Benefit Solutions model around:
- Transparency, so you know where your money goes
- Efficiency, by cutting out unnecessary layers and costs
- Member-first solutions, like $0 copays and better access to essential medications
Our Rx Optimization Program helps employers take control by reducing waste, capturing savings, and ensuring employees get the medications they need without breaking the bank.
Because of InterceptRx’s aligning with national efforts and embracing smarter pharmacy benefit models, companies can lower their healthcare spend, improve member satisfaction, and help shape a more affordable, equitable future in pharmacy care.
Bottom line? Whether you’re focused on savings, fairness, or both, we’re here to help you lead the way.
The current state of prescription drug pricing: Why costs keep rising
Did you know? The average annual drug spend per person in the U.S. is now around $1,500.² This figure reflects a broader issue: pharmacy benefit costs are escalating faster than most other areas of healthcare, and traditional approaches are no longer enough to contain them.
So, what’s driving these higher costs?
- Inflation: Just like groceries and gas, the cost of making, packaging, and distributing medications has gone up. And those increases get passed straight down the line to payers and patients.
- Supply chain issues: Global disruptions, from material shortages to shipping delays, make it harder to get medications where they need to go. That limited supply can push prices even higher.
- Specialty medications: These powerful therapies treat chronic, rare, or complex conditions. They’re often worth every penny but those pennies add up fast. Specialty drugs now make up a huge slice of total pharmacy benefit spending.
With all these challenges combined, it’s unlikely that prescription prices will level off anytime soon.
What Can Employers and Brokers Do?
The old “set it and forget it” approach to pharmacy benefits doesn’t work anymore. Now, it’s all about being proactive and strategic.
Employers and brokers need to:
- Partner with transparent, forward-thinking PBMs
- Explore new tools and solutions that actually manage spend
- Make sure employees still have access to the meds they need—without breaking the bank
Want to get ahead of the cost curve? That’s where smarter programs like Intercept Rx’s Rx Optimization Program can make a real difference.
Employers and brokers must take a proactive, informed approach to benefit management, seeking out transparent partners, embracing smarter pharmacy solutions, and exploring new strategies to mitigate rising costs while protecting employee access.
Predicted drug pricing trends for the second half of 2025
The second half of 2025 is shaping up to be a turning point for pharmacy benefits. From rising specialty drug use to new tech tools and tighter regulations, big changes are coming and they’ll affect how medications are priced, accessed, and managed.
Employers and brokers who stay ahead of these trends will be in a much stronger position to protect budgets and keep their teams healthy and supported.
Let’s take a look at what’s coming:
Specialty medications are still the #1 cost driver
Specialty medications, used to treat chronic, complex, or rare conditions are taking up a bigger and bigger share of drug spending. In fact, they’re expected to make up 60% of total prescription costs by the end of 2025.
For employers, this means serious financial pressure. If there’s no plan in place, specialty drugs can blow through budgets and limit access for employees who really need them.
What helps? Pharmacy benefit strategies that include:
- Smarter sourcing and contracting
- Patient support tools
- A clear plan for managing high-cost therapies
These high-cost therapies are projected to account for up to 60% of total prescription drug spending by the end of 2025, making them the most influential factor in overall plan costs.
New rules are changing the game
Government regulations are starting to reshape how drug prices work:
- Federal efforts, like drug price negotiations, are pushing manufacturers to lower the price of expensive medications.
- States are rolling out their own rules, think price caps, transparency laws, and anti-gouging protections.
These changes are good news for cost control but they also make benefit compliance more complicated, especially for companies operating across multiple states. Staying flexible and informed is key.
Biosimilars = Big savings on the table
Here’s a huge opportunity: biosimilars. These are safe, effective, lower-cost versions of pricey biologic drugs and they’re gaining ground fast.
Experts estimate biosimilars could save the U.S. healthcare system up to $133 billion by the end of 2025.³ For employers and PBMs, promoting biosimilars through smart plan design, education, and incentives can lead to major cost reductions without cutting corners on care.
Tech is taking center stage: AI + Blockchain
Pharmacy benefit management is getting a serious upgrade thanks to emerging tech:
- AI tools are now being used to track drug prices in real time, forecast spending, and support smarter plan design. That means fewer surprises and more control.
- Blockchain is being explored to create transparent, secure pricing records helping eliminate hidden fees and shady markups.
If your PBM isn’t exploring these tools, it’s time to ask why.
So why does all this matter?
Because employers and brokers who plan ahead and adapt now will:
✅ Keep costs under control
✅ Stay compliant and competitive
✅ Offer better benefits that actually support employee well-being
Whether it’s embracing biosimilars, adopting smarter tech, or aligning with new regulations, proactive pharmacy benefit planning is the name of the game in 2025.
Rising drug costs = More pressure on employers
Let’s face it, prescription drug prices are going up, and it’s creating real headaches for employers. If you’re managing a self-funded or level-funded pharmacy plan, you’re probably feeling the pinch.
As medication prices climb, so do budget concerns. But here’s the tricky part: while you’re trying to cut costs, you still need to offer benefits that keep your employees healthy, productive, and happy. That balance is hard and it’s become a top priority for HR teams, CFOs, and benefits managers everywhere.
How Intercept Rx helps employers take control
That’s where Intercept Rx’s Rx Optimization Program comes in.
Instead of sticking with the same old expensive benefit model, we give employers a smarter way to manage pharmacy costs without sacrificing quality or access.
Here’s how it works:
- We use data and real-time insights to spot savings opportunities
- We negotiate better pricing with drug suppliers and partners
- We help steer employees toward affordable, clinically effective options
The result? Lower pharmacy costs, better employee access to the medications they need, and fewer budget surprises.
In short: More control for employers. More value for teams.
How rising drug costs are hurting employees
It’s not just employers feeling the impact of rising prescription prices, employees are taking a hit too. And when cost-saving strategies aren’t in place, the consequences can show up fast in both health and productivity.
Out-of-pocket costs are weighing people down
When pharmacy benefits don’t keep up with pricing trends, employees end up paying more out of their own pockets. This is especially tough for those managing chronic conditions or who need specialty medications, the ones with the highest price tags.
The result? Financial stress, skipped refills, and growing frustration.
People are actively looking for cheaper options
As drug prices keep climbing, employees are getting creative. They’re looking for more affordable options like generics, biosimilars, and programs that help cut down on copays or out-of-pocket costs.
What they really need? A benefit plan that’s designed with affordability and access in mind.
Delayed care = Lost productivity
Did you know? 38% of employees have postponed treatment due to cost concerns, including the high price of prescription drugs.⁴
And that delay doesn’t just hurt their health. It leads to:
- More sick days
- Lower energy and productivity
- Bigger health issues down the road
The best way to turn that around? Offer a pharmacy plan that truly supports your team, one that keeps medications affordable and within reach.
That’s where the Rx Optimization Program from Intercept Rx comes in. It gives employers the tools to control costs and helps employees stay on track with their care so everyone wins.
How Intercept Rx helps you take control of drug costs
With prescription prices continuing to climb, employers need more than just a traditional pharmacy plan they need a smarter, more strategic solution.
That’s where Intercept Rx comes in.
Through our Rx Optimization Program, we help companies cut through the noise, reduce waste, and keep medication access affordable for both employers and their teams.
The Rx Optimization Program: Real savings, real impact
This isn’t your average PBM offering. The Rx Optimization Program was built to deliver real, measurable savings especially in areas where costs are spiraling, like specialty medications.
Here’s how we do it:
- We negotiate better pricing to get you more value per dollar
- We cut out inefficiencies that drive up costs without adding value
- We improve access to medications that are both cost-effective and clinically appropriate
And the best part? You don’t have to sacrifice employee experience to do it. In fact, you’ll boost satisfaction by offering a benefits package that makes life easier for your people.
With a focus on cost-containment, smart tech, and transparency, Intercept Rx gives brokers and employers the tools they need to stay competitive without overpaying for pharmacy care.
Planning ahead is no longer optional, it’s a must
With drug prices continuing to climb, waiting and reacting just isn’t an option anymore. If you want to keep costs under control and benefits competitive, it’s time to think ahead.
From the rise of specialty medications to changing regulations and higher employee expectations there’s a lot to stay on top of. But you don’t have to do it alone.
That’s where Intercept Rx comes in
Whether you’re running a self-funded or level-funded plan, Intercept Rx gives you the tools, insights, and support to:
✅ Cut unnecessary costs
✅ Simplify benefit management
✅ Keep your workforce healthy, happy, and productive
Whether you’re managing a self-funded or level-funded plan, Intercept Rx helps ensure your benefits remain competitive, affordable, and aligned with the needs of today’s workforce.
Ready to take control of rising drug costs?
Let’s make pharmacy benefits work smarter for your business and your team.
Help Your Clients Save Big on Pharmacy Benefits
Impress your clients with a smart, no-cost analysis that uncovers hidden pharmacy benefit savings.
